Candel Therapeutics (CADL) Cash from Operations (2020 - 2025)
Candel Therapeutics recorded quarterly Cash from Operations of 10568000.0 in Q4 2025, down 3.24% quarter-over-quarter from 10236000.0 in Q3 2025, and down 81.77% year-over-year from 57964483.02 in Q4 2024.
Candel Therapeutics' Cash from Operations history runs 6 years deep, the most recent figure standing at 10568000.0 for Q4 2025.
- In Q4 2025, Cash from Operations fell 81.77% year-over-year to 10568000.0; the TTM figure through Dec 2025 stood at 38311000.0 (down 41.77% YoY), while the FY2025 annual figure was 38311000.0, down 41.77% from the prior year.
- Cash from Operations came in at 10568000.0 for Q4 2025 at Candel Therapeutics, down from 10236000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 4459000.0 in Q2 2021 to a low of 10819000.0 in Q1 2023.
- A 5-year average of 7660750.0 and a median of 7308500.0 in 2023 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations tumbled 358.07% in 2021 and gained 25.37% in 2024, its largest moves.
- Candel Therapeutics' Cash from Operations stood at 5238000.0 in 2021, then sank by 31.44% to 6885000.0 in 2022, then decreased by 7.8% to 7422000.0 in 2023, then increased by 21.67% to 5814000.0 in 2024, then tumbled by 81.77% to 10568000.0 in 2025.
- According to Business Quant data, Cash from Operations over the past three periods registered 10568000.0, 10236000.0, and 8891000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Candel Therapeutics | 449.62 Mn | 449.62 Mn | - | -10.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10.57 Mn |
| Dec 31, 2025 | -10.57 Mn |
| Sep 30, 2025 | -10.24 Mn |
| Sep 30, 2025 | -10.24 Mn |
| Jun 30, 2025 | -8.89 Mn |
| Jun 30, 2025 | -8.89 Mn |
| Mar 31, 2025 | -8.62 Mn |
| Mar 31, 2025 | -8.62 Mn |
| Dec 31, 2024 | -5.81 Mn |
| Dec 31, 2024 | -5.81 Mn |
| Sep 30, 2024 | -6.57 Mn |
| Sep 30, 2024 | -6.57 Mn |
| Jun 30, 2024 | -6.20 Mn |
| Jun 30, 2024 | -6.20 Mn |
| Mar 31, 2024 | -8.44 Mn |
| Mar 31, 2024 | -8.44 Mn |
| Dec 31, 2023 | -7.42 Mn |
| Dec 31, 2023 | -7.42 Mn |
| Sep 30, 2023 | -8.81 Mn |
| Sep 30, 2023 | -8.81 Mn |
| Jun 30, 2023 | -7.20 Mn |
| Jun 30, 2023 | -7.20 Mn |
| Mar 31, 2023 | -10.82 Mn |
| Mar 31, 2023 | -10.82 Mn |
| Dec 31, 2022 | -6.89 Mn |
| Dec 31, 2022 | -6.89 Mn |
| Sep 30, 2022 | -9.38 Mn |
| Sep 30, 2022 | -9.38 Mn |
| Jun 30, 2022 | -7.10 Mn |
| Jun 30, 2022 | -7.10 Mn |
| Mar 31, 2022 | -8.05 Mn |
| Mar 31, 2022 | -8.05 Mn |
| Dec 31, 2021 | -5.24 Mn |
| Dec 31, 2021 | -5.24 Mn |
| Sep 30, 2021 | -6.89 Mn |
| Sep 30, 2021 | -6.89 Mn |
| Jun 30, 2021 | -4.46 Mn |
| Jun 30, 2021 | -4.46 Mn |
| Mar 31, 2021 | -5.63 Mn |
| Mar 31, 2021 | -5.63 Mn |
| Dec 31, 2020 | -3.42 Mn |
| Dec 31, 2020 | -3.42 Mn |
| Sep 30, 2020 | -1.51 Mn |
| Sep 30, 2020 | -1.51 Mn |